Fluorescent lymphography and lymph node retrieval and perioperative outcomes in rectal cancer surgery: a prospective non-randomized cohort study stratified by neoadjuvant chemoradiotherapy
This prospective cohort study demonstrates that fluorescence lymphography improves lymph node retrieval and perioperative outcomes in rectal cancer surgery, particularly for patients not receiving neoadjuvant chemoradiotherapy, although its sensitivity for detecting metastatic lymph nodes remains limited.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the complex landscape of rectal cancer surgery, the goal is not merely to remove a tumor but to ensure the body's drainage system is cleared of any hidden threats. The standard procedure for mid-to-low rectal cancer involves a meticulous operation called total mesorectal excision, where surgeons remove the tumor along with the surrounding tissue and the network of lymph nodes that drain that area. These lymph nodes act as the body's first line of defense, filtering fluid and trapping cancer cells before they can spread elsewhere. Because the presence of cancer in these nodes is one of the most critical factors in determining a patient's prognosis, surgeons strive to retrieve as many as possible during the operation. However, finding every single node is difficult; they are tiny, often hidden within fatty tissue, and their visibility can be compromised by prior treatments. This challenge has led researchers to explore new ways to illuminate the hidden pathways of the body, specifically using a technique that turns the invisible lymphatic system into a glowing map during surgery.
A recent study conducted by researchers at the National Cancer Center in China and Aviation General Hospital investigated whether a technique called fluorescent lymphography could help surgeons find more lymph nodes and improve patient recovery. The team followed 461 patients who underwent surgery for rectal cancer between 2019 and 2023. The majority of patients received the standard surgical approach, while a smaller group underwent a procedure guided by a special dye. Before their operations, these patients received an injection of a substance called indocyanine green, which is harmless and glows brightly when exposed to a specific type of light. During the surgery, the surgeons used a camera that could see this glow, allowing them to see the lymphatic channels and the nodes they led to in real time. If the glowing nodes appeared in areas the surgeons had not planned to cut, they would extend their dissection to remove them. The researchers then compared the two groups to see if this glowing guide made a difference in how many nodes were found, how long the surgery took, and how well the patients recovered.
The results showed that the glowing guide did indeed help surgeons find more lymph nodes, but the benefit depended heavily on whether the patient had received radiation and chemotherapy before the operation. For patients who had not undergone this preoperative treatment, the fluorescent technique was highly effective. These surgeons retrieved an average of nearly 29 lymph nodes per patient, compared to about 27 for those without the guide. More importantly, a significantly higher percentage of these patients had enough nodes removed to meet the rigorous standards required for accurate cancer staging. The surgery itself was also more efficient for this group; the operations were shorter, the amount of blood lost was significantly lower, and patients returned to eating soft foods and leaving the hospital much faster. In fact, patients without preoperative treatment who received the fluorescent guidance stayed in the hospital for an average of just over six days, compared to nearly 15 days for those who did not.
However, the story changed for patients who had received neoadjuvant chemoradiotherapy, a common treatment for locally advanced rectal cancer designed to shrink the tumor before surgery. In this group, the glowing dye did not help surgeons find more lymph nodes. The average number of nodes retrieved was similar between the two groups, and the technique did not make the surgery faster or reduce blood loss. The researchers suggest that the radiation and chemotherapy likely caused scarring and changes in the tissue that blocked the dye from traveling through the lymphatic system as it normally would, making the "glow" less reliable. Despite this, the technique still offered a small benefit: patients in the fluorescent group who had received preoperative treatment still left the hospital sooner than those who did not.
The study also examined how well the glowing dye could actually predict which lymph nodes contained cancer. The researchers found that the dye was not a perfect detector. It missed a significant number of cancerous nodes, meaning that relying on the glow alone would not be enough to rule out the spread of cancer. The dye was better at confirming that a node was likely free of cancer if it did not glow, but it could not guarantee that a glowing node was cancerous. This limitation was even more pronounced in patients who had received preoperative treatment. The study concluded that while the fluorescent technique is a valuable tool for helping surgeons navigate the anatomy and remove more tissue, it should be viewed as a helpful assistant rather than a standalone diagnostic tool. It works best for patients who have not had prior radiation, offering a clearer path through the body's complex drainage system and leading to quicker recoveries, but its ability to spot hidden cancer cells remains limited, especially after the tissue has been altered by chemotherapy and radiation.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.